RGW-611

Details

Stereochemistry	ACHIRAL
Molecular Formula	C9H14N4O3
Molecular Weight	226.2325
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[O-][N+](=O)C1=CN(CCN2CCOCC2)C=N1

InChI

InChIKey=VDZAAIIQCHGJAD-UHFFFAOYSA-N

InChI=1S/C9H14N4O3/c14-13(15)9-7-12(8-10-9)2-1-11-3-5-16-6-4-11/h7-8H,1-6H2

HIDE SMILES / InChI

Molecular Formula	C9H14N4O3
Molecular Weight	226.2325
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
fatty acid biosynthetic process 1 Target ID: GO:0006633 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7325993	Activator 1447

Substance Class	Chemical Created by `admin` on `Wed Apr 02 17:51:18 GMT 2025` Edited by `admin` on `Wed Apr 02 17:51:18 GMT 2025`
Record UNII	7QC7E66DRA
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RGW611

Preferred Name

English

RGW-611

Code

English

Morpholine, 4-[2-(4-nitro-1H-imidazol-1-yl)ethyl]-

Systematic Name

English

4-[2-(4-Nitro-1H-imidazol-1-yl)ethyl]morpholine

Systematic Name

English

Morpholine, 4-[2-(4-nitroimidazol-1-yl)ethyl]-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID00879596

Created by admin on Wed Apr 02 17:51:18 GMT 2025 , Edited by admin on Wed Apr 02 17:51:18 GMT 2025

PRIMARY

PUBCHEM

23274333

Created by admin on Wed Apr 02 17:51:18 GMT 2025 , Edited by admin on Wed Apr 02 17:51:18 GMT 2025

PRIMARY

FDA UNII

7QC7E66DRA

Created by admin on Wed Apr 02 17:51:18 GMT 2025 , Edited by admin on Wed Apr 02 17:51:18 GMT 2025

PRIMARY

CAS

6497-78-5

Created by admin on Wed Apr 02 17:51:18 GMT 2025 , Edited by admin on Wed Apr 02 17:51:18 GMT 2025

PRIMARY